Peripheral Blood Stem Cell TransplantationStem CellsHematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell MobilizationHematopoietic Stem CellsStem Cell TransplantationTransplantation, HomologousLeukapheresisTissue DonorsCord Blood Stem Cell TransplantationGranulocyte Colony-Stimulating FactorAntigens, CD34Embryonic Stem CellsBlood Component RemovalTransplantation ConditioningGraft vs Host DiseaseAdult Stem CellsBone Marrow TransplantationGraft SurvivalHematologic NeoplasmsBlood DonorsPluripotent Stem CellsMelphalanCell DifferentiationCombined Modality TherapyCyclophosphamideStem Cell NicheCloning, OrganismTransplantation ChimeraInduced Pluripotent Stem CellsBusulfanNeural Stem CellsHematopoiesisMultiple MyelomaBlood CellsMesenchymal Stem Cell TransplantationFetal BloodStem Cell FactorAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeMultipotent Stem CellsBlood Cell CountCell LineageNuclear Transfer TechniquesMesenchymal Stromal CellsBone Marrow CellsHistocompatibilityWhole-Body IrradiationLiving DonorsCells, CulturedAntineoplastic Agents, AlkylatingHistocompatibility TestingRecurrenceCell SeparationLymphoma, Non-HodgkinThiotepaEtoposideRemission InductionColony-Forming Units AssayMyeloablative AgonistsFlow CytometryLeukemiaTime FactorsFetal Stem CellsBone MarrowVidarabineStem Cell ResearchInfectionMice, Inbred C57BLChimeraTransplantation, IsogeneicPlant StemsCell Culture TechniquesImmunosuppressive AgentsCell ProliferationPlatelet CountDisease-Free SurvivalIfosfamideLeukocyte TransfusionSurvival RateBone Marrow PurgingImmunophenotypingRecombinant ProteinsImmunomagnetic SeparationSalvage TherapyCytarabinePOEMS SyndromeRetrospective StudiesAntigens, CDMice, SCIDHodgkin DiseaseVincristineCell CountLeukemia, Myeloid, AcuteHematologic DiseasesTotipotent Stem CellsSurvival AnalysisCell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL Positive